PTX 111

Drug Profile

PTX 111

Alternative Names: PTX-111

Latest Information Update: 01 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Phytrix
  • Class Antivirals
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Hepatitis B; HIV-1 infections

Most Recent Events

  • 01 Feb 2011 No development reported - Phase-II for Hepatitis B in India (unspecified route)
  • 01 Feb 2011 No development reported - Phase-II for HIV-1 infections in Germany (unspecified route)
  • 19 Dec 2005 PTX 111 is available for licensing (http://phytrix.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top